Bravelle
Recall
|
Medicines
|
23/10/2015
The marketing authorization holder has informed its supplied customers in a letter dated October 22, 2015, that the stability of "Bravelle 75 I.U. Powder and Solvent for Solution for Injection" cannot be safely guaranteed until the stated expiry date based on the results of routine stability tests. Therefore, a precautionary recall of the batches in the maturity period is being implemented.
| Name of the medicinal product | Bravelle 75 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
|---|---|
| Marketing authorisation number(s) | 1-26268 |
| Marketing authorisation holder | Ferring Arzneimittel Ges.m.b.H |
| Batch number(s) | L11680F, K13513M, K12892E |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 1537 |
Further inquiry note
Page last modified:
12/07/2022